Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews.
- DOI
- 10.1007/s43441-025-00855-2
- Published
- 2026 Jan
- Container
- Therapeutic innovation & regulatory science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s43441-025-00855-2,
title = {Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews.},
author = {Claessens Z and Beirne G and Decouttere C and Vandaele N and Barbier L and Huys I},
year = {2026},
journal = {Therapeutic innovation \& regulatory science},
doi = {10.1007/s43441-025-00855-2},
url = {https://doi.org/10.1007/s43441-025-00855-2}
}RIS
TY - JOUR TI - Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews. AU - Claessens Z AU - Beirne G AU - Decouttere C AU - Vandaele N AU - Barbier L AU - Huys I PY - 2026 JO - Therapeutic innovation & regulatory science DO - 10.1007/s43441-025-00855-2 UR - https://doi.org/10.1007/s43441-025-00855-2 ER -
APA
Z, C., G, B., C, D., N, V., L, B., & I, H. (2026). Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews.. Therapeutic innovation & regulatory science. https://doi.org/10.1007/s43441-025-00855-2
Source records
- pubmed · retrieved 2026-09-26T11:22:41.709Z